Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs
Immunovia, the diagnostics company that has launched the world’s first blood test dedicated to the […]
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
Full-Life Technologies has announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer […]
Eagle Genomics Disclose Funding from OMRON Ventures to Drive Sustainability Innovation in Microbiome R&D
Today, Eagle Genomics, the pioneering TechBio platform business applying network science to biology, disclosed additional […]
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
CARsgen Therapeutics, a company focused on innovative CAR T-cell therapies for the treatment of hematologic […]
NHS Delivers 20 Million Flu Jabs As Critical Care Cases Rise
More than 20 million people in England have had their flu jabs as the number […]
Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors
Relmada Therapeutics, a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today […]
Novotech Acquires European CRO EastHORN, Strengthens Global Operations
Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory […]
Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease
Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities
Armata Pharmaceuticals, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial […]
JanOne Completes Acquisition of Soin Therapeutics
JanOne, a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more